Covered recipient · General Payments record
KIM RICHARD JURELL
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2021
$474.68
- Reported across 33 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $231.50 | 17 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $146.58 | 11 |
| Celgene Corporation | $29.73 | 2 |
| PFIZER INC. | $16.30 | 1 |
| Pharmacosmos Therapeutics Inc. | $14.16 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.42 | 1 |
| Ferring Pharmaceuticals Inc. | $11.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $3.87 | 01/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795004201 | CMS |
| AbbVie Inc. | $6.73 | 02/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795004205 | CMS |
| AbbVie Inc. | $14.56 | 03/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795004209 | CMS |
| AbbVie Inc. | $3.39 | 03/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795004213 | CMS |
| AbbVie Inc. | $19.75 | 03/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795004217 | CMS |
| AbbVie Inc. | $5.99 | 04/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795004221 | CMS |
| AbbVie Inc. | $25.76 | 05/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795004225 | CMS |
| AbbVie Inc. | $3.56 | 06/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795004229 | CMS |
| AbbVie Inc. | $27.52 | 06/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795004233 | CMS |
| AbbVie Inc. | $24.72 | 08/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795004237 | CMS |
| AbbVie Inc. | $10.73 | 09/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795004241 | CMS |
| Celgene Corporation | $15.42 | 06/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 783693841 | CMS |
| Celgene Corporation | $14.31 | 07/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 783693845 | CMS |
| Ferring Pharmaceuticals Inc. | $11.31 | 07/21/2021 | Food and Beverage | Undisputed | 01/23/2026 | 771564690 | CMS |
| PFIZER INC. | $16.30 | 08/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 832764413 | CMS |
| Pharmacosmos Therapeutics Inc. | $14.16 | 07/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 842721921 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.42 | 12/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 820003275 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.